← Back to Clinical Trials
Recruiting NCT06835842

NCT06835842 Effect of Rib Mobilization on Weaning Parameters From Mechanical Ventilator in Patients With Pneumonia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06835842
Status Recruiting
Phase
Sponsor Cairo University
Condition Pneumonia
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-03-10
Primary Completion 2026-02-10

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
rib mobilization techniqueroutine chest physiotherapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-03-10 with a primary completion date of 2026-02-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

this study will be conducted to distinguish between effect of rib mobilization and routine chest physiotherapy on weaning parameters from mechanical ventilator in patients with pneumonia • HYPOTHESES: It will be hypothesized that there may be significant effect of rib mobilization on weaning parameters from mechanical ventilator in patients with pneumonia. RESEARCH QUESTION: Does rib mobilization have an effect on weaning parameters from mechanical ventilator in patients with pneumonia? measuring weaning parameters: on screen of mechanical ventilator : measuring respiratory rate, Tidal volume (TV), FiO2. * Arterial blood gases (ABG) analyzer machine ABG is recorded daily (PH- PaO2 - PaCO2) * Length of ICU stay: calculated by (admission date - discharge date * Weaning success rate

Eligibility Criteria

Inclusion Criteria: 1. Patient's age ranged from 40- 50 years old from both genders. 2. Diagnosed with pneumonia and need invasive mechanical ventilation support. 3. Stable oxygen saturation (SpO2 more than 85, (FiO2) 0.6 or less, PEEP less than 10 Cm H2O). 4. mean arterial pressure \> 75 mmHg and urine output \> 1 mL/kg/h; 5. Patients with Glasgow coma scale (GCS) \> 8T 6. Unconscious and semi-conscious patients. - Exclusion Criteria: 1. Unstable hemodynamics 2. Unstable neurological problems e.g. (epileptic seizures -hyperthermia). 3. Unstable chest wall e.g. (multiple rib or vertebral fractures) 4. Increase intracranial pressure (\>20 mmHg for \>5 min). 5. Undrained pneumothorax, recent pulmonary surgery

Contact & Investigator

Central Contact

hoda gaber el said, master

✉ huda.eaid68@gmail.com

📞 01100272020

Principal Investigator

Azza Abd El Aziz Abd El Hady, professor

STUDY CHAIR

Cairo University

Frequently Asked Questions

Who can join the NCT06835842 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 50 Years, studying Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06835842 currently recruiting?

Yes, NCT06835842 is actively recruiting participants. Contact the research team at huda.eaid68@gmail.com for enrollment information.

Where is the NCT06835842 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06835842 clinical trial?

NCT06835842 is sponsored by Cairo University. The principal investigator is Azza Abd El Aziz Abd El Hady, professor at Cairo University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology